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Detailed stopped-flow studies in combination with
site-directed mutagenesis, isothermal titration calorim-
etry data and x-ray crystallographic knowledge have
revealed that the biphasic pre-equilibrium fluorescence
changes reported for a single Ig-binding domain of pro-
tein L from Peptostreptococcus magnus binding to 
light chain are due to the binding of the  light chain at
two separate sites on the protein L molecule. Elimina-
tion of binding site 2 through the mutation A66W has
allowed the Kd for  light chain binding at site 1 to be
measured by stopped-flow fluorescence and isothermal
titration calorimetry techniques, giving values of 48.0 
8.0 nM and 37.5  7.3 nM respectively. Conversely, a dou-
ble mutation Y53F/L57H eliminates binding at site 1 and
has allowed the Kd for binding at site 2 to be determined.
Stopped-flow fluorimetry suggests this to be 3.4  0.8 M
in good agreement with the value of 4.6  0.8 M deter-
mined by isothermal titration calorimetry. The muta-
tion Y53F reduces the affinity of site 1 to approximately
that of site 2.
Protein L is a multidomain cell wall bound protein found in
10% of the Peptostreptococcal isolates (1) and contains a
series of repeated domains, some of which are able to bind to
immunoglobulins without initiating an immune response. Ex-
pression of this protein has been correlated to the virulence of
these opportunistic pathogenic bacteria (1) that are found in
the gastrointestinal and urogenital tracts (2). Its presence has
been found to cause cellular responses such as histamine re-
lease from basophils and mast cells (3) presumably by cross-
linking IgE molecules bound to surface Ig receptors.
1H NMR spectroscopy of a single Ig-binding domain of pro-
tein L (isolated from strain 312, PpL312)
1 revealed that PpL312
is a rigid structure consisting of a -sheet, formed by two pairs
of antiparallel -strands, lying on top of a single -helical
section (4), with a flexible N terminus (5). Further NMR studies
(6) led to the proposal that the binding site of PpL312 for -chain
involves residues from the second -strand and from the loop
between the third -strand and the -helix and located the
binding site for PpL312 on the -chain to the second -strand
and the two -strands located on the outer surface of the
framework region of the VL domain (7).
Parallel studies on the binding interaction of a single Ig-
binding domain of protein L from strain 3316 (PpL3316) found
that it forms a high affinity complex with -chains with a Kd of
112 nM (8, 9). The x-ray crystallographic structure of this do-
main has been determined in complex with the human anti-
body fragment, Fab 2A2, and revealed that two Fab 2A2 frag-
ments can in fact bind to sites on opposite faces of PpL3316 (10).
Site 1 of PpL3316 is that characterized by Beckingham et al. (9)
and equivalent to the site studied on PpL312 using NMR by
Wikstro¨m et al. (5). Site 2 of PpL3316, involving part of the helix
and strands 3 and 4, was identified for the first time by the
crystallographic study (10). This site has not yet been charac-
terized although preliminary studies suggested that the affin-
ity of site 2 is lower than that of site 1 (10).
By use of a program of site directed mutagenesis we have
been able to derive the relative binding affinities of sites 1 and
2 and propose a mechanism by which PpL3316 binds  light
chains that is consistent with published data. The hydroxyl
group of Tyr53 is important for the formation of a high affinity
complex at site 1. Previous enzyme-linked immunosorbent as-
say experiments (11) have shown that nitration of Tyr53 or its
mutation to Phe dramatically increases the Kd of the -chain-
PpL3316 interaction. Another important residue at site 1 is
Leu57. No binding of the 1-chain used in these studies can be
detected at site 1 of the mutant Y53F/L57H by fluorimetry or
isothermal titration calorimetry, and this mutant is thus ideal
for measuring the affinity at site 2.
Important residues for binding at site 2 are Asp55 and Ala66.
The mutation D55A eliminates a salt bridge and dramatically
weakens or eliminates binding (12), and conversely, the muta-
tion A66W is predicted to cause a steric clash removing binding
at site 2. This is born out by fluorimetry experiments reported
here and therefore the A66W PpL3316 is suitable for determin-
ing the affinity of site 1.
The fluorescence properties of tryptophan residues are
highly sensitive to their immediate environment (13), and
changes in the fluorescence emission from Trp residues have
been used to study protein folding and unfolding events, pro-
* This work was supported by the Wellcome Trust and Biotechnology
and Biological Sciences Research Council Grants 055640/Z/98/Z/ST/RC,
E10136, E15767, and E11896 (to M. G. G.). The costs of publication of
this article were defrayed in part by the payment of page charges. This
article must therefore be hereby marked “advertisement” in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
§ These authors received a Biotechnology and Biological Sciences
Research Council studentship.
 To whom correspondence should be addressed: Dept. of Biochemis-
try, School of Biological Sciences, University of Southampton, Bassett
Crescent East, Southampton, Hants SO16 7PX, UK. Tel.: 44-23-
80594313; Fax: 44-23-80594459; E-mail: M.G.Gore@soton.ac.uk.
1 The abbreviations used are: PpL312, single Ig-binding domain of
protein L from strain 312 of P. magnus; PpL3316, single Ig-binding
domain of protein L from strain 3316 of P. magnus; -chain,  light
chain; wt, wild-type; FRET, fluorescence resonance energy transfer.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 279, No. 10, Issue of March 5, pp. 9370–9378, 2004
© 2004 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www.jbc.org9370
tein conformational changes, and to monitor binding interac-
tions between proteins and various ligands (14). We have there-
fore introduced unique Trp residues into PpL3316 to monitor the
binding reaction with -chain. Previous fluorescence studies
have used F39W PpL3316 to report the binding interaction
between -chain and PpL3316. However, upon introduction of
secondary mutations into the F39W PpL3316 construct, expres-
sion levels and stability of the protein are compromised. There-
fore the I34W PpL3316 mutant, which has a Trp residue located
toward the N terminus of -strand 2, has been selected to study
binding at the site 1 interface (see Fig. 1a); this construct is
tolerant to the introduction of further mutations. The mutant
Y64W PpL3316 (Trp residue on -strand 3 and close to residues
Thr65, Ala66, Asp67, and Leu68, all of which are involved in site
2 contacts (10)) was made to monitor binding at site 2 (see
Fig. 1b).
EXPERIMENTAL PROCEDURES
Phosphate buffers and other reagents were all of analytical grade
and purchased from BDH. The human IgG and 1-chain for fluorescence
experiments were generous gifts from Professor Martin Glennie,
Southampton General Hospital, UK.
Mutagenesis—The mutated PpL3316 constructs, I34W, Y64W, and
Y64W/Y53F, were produced through the Kunkel method (15) of site-
directed mutagenesis. The I34W/Y53F, I34W/Y53F/L57H, Y64W/Y53F/
L57H, A66W, and I34W/A66W PpL3316 mutant proteins were made
through two-sided splicing by overlap extension PCR mutagenesis (16).
The presence of each mutation was confirmed by DNA sequencing and
the mutant proteins were prepared in the same manner as the wild-
type (wt) protein (8).
Fluorescence Measurements—Fluorescence emission spectral meas-
urements were made on a Hitachi F-2000 fluorimeter, with the tem-
perature of the cell being maintained at 15 °C by circulating water. All
solutions were prepared in filtered 20 mM potassium phosphate buffer,
pH 8.0. Scans of the emission spectra were made using excitation and
emission band passes of 5 nm. Emission spectra were measured using
excitation wavelengths of 280 and 295 nm, with a scan rate of 60
nm/min.
Stopped-flow Fluorescence Measurements—An Applied Photophysics
SX.17MV stopped-flow spectrophotometer fitted with a 2-ml syringe
was used to study pre-equilibrium fluorescence changes upon mixing of
PpL3316 with -chain. The temperature was maintained at 15 °C (unless
otherwise stated) using a Neslab RTE-111 circulating water bath.
Measurements were made over various time courses between 0.2 and
200s, collecting 1000 data points with oversampling activated. Excita-
tion wavelengths of 280 or 295 nm were selected by a monochromator
and fluorescence emission above 335 nm was selected using a cut-off
filter. All solutions were prepared in filtered and degassed 20 mM
potassium phosphate buffer, pH 8.0. Each reaction was carried out in
triplicate and the data averaged and analyzed using the manufacturer’s
software and single or double exponential curve fitting algorithms.
For the determination of the rate constants for the association and
dissociation of the complex, the concentration of -chain was kept at 1.5
M, and the concentrations of the PpL3316 mutants were varied between
10 and 50 M. Alternatively, in some experiments the concentration of
PpL3316 was kept constant at 1.5 M, and the concentration of -chain
was varied.
To study the rate of dissociation of the complexes formed between
PpL3316 mutants and -chain, a solution containing a preformed com-
plex (3 M -chain and 3 M mutant PpL3316) was rapidly diluted by an
equal volume of the non-fluorescent (above 335 nm) wt PpL3316 (30 M).
All concentrations quoted are final concentrations after 1:1 v/v mixing.
Sequential Mixing Stopped-flow Fluorimetry—To identify any inter-
mediate complexes in the formation of the equilibrium complex between
the PpL3316 and -chain, the stopped-flow fluorimeter was reconfigured
to facilitate sequential mixing. Initially 6 M Trp-labeled PpL3316 (i.e.
I34W or Y64W PpL3316) was mixed with an equal volume of 6 M
-chain. After a delay to allow complex formation (50 ms to 50 s), the 3
M Trp-labeled PpL3316, 3 M -chain solution was mixed with an equal
volume of 30 M wt PpL3316 in 20 mM potassium phosphate buffer, pH
8.0, causing dissociation of the Trp labeled PpL3316-chain complex.
Upon initiation of the second mixing step, fluorescence emissions above
335 nm were monitored over appropriate time courses.
Isothermal Titration Calorimetry—Isothermal titration calorimetry
was carried out using a Microcal VP-ITC at 15 °C, with protein solu-
tions prepared in 20 mM potassium phosphate buffer, pH 8.0. The
interaction of wt PpL3316 with -chain was studied through the titration
of aliquots of 360 M -chain into 15 M wt PpL3316. Heat changes
associated with the dilution of the -chain were measured by the titra-
tion of aliquots of 360 M -chain into 20 mM potassium phosphate
buffer, pH 8.0. The enthalpy profile for the control titration into buffer
was subtracted from the experimental data, with the resulting binding
data being analyzed using the manufacturer’s software.
To further resolve the binding interactions of -chain at sites 1 and 2
of PpL3316, mutant PpL3316 constructs with site 2 or site 1 eliminated
(737 and 650 M, respectively) were titrated into -chain (28.3 and 25
M, respectively). As above, binding data from these titrations were
analyzed using the manufacturer’s software.
Circular Dichroism—CD measurements were made using a Jasco
J-720 CD spectrometer thermostated at 15 °C. The spectra between 195
and 250 nm were measured at a scan rate of 50 nm/min using a 1-mm
path length. The spectra were scanned in triplicate, with a response
time of 4 s, slitwidth of 500 m, bandwidth of 1.0 nm, and resolution of
0.2 nm. Spectral corrections and calculations were carried out using the
manufacturer’s software, and the units are given in mean residue
ellipticity.
RESULTS AND DISCUSSION
Changes in the environment of the Trp reporter groups were
examined by comparing the emission spectra of 1.5 M -chain
and 1.5 M of each of the PpL3316 mutants, in free solution and
complex, using excitation wavelengths of 280 and 295 nm. The
spectra showed that Trp64 and Trp34 have wavelengths of max-
imum emission at 335 and 345 nm, respectively, indicating that
Trp64 is in a more hydrophobic environment than Trp34. The
latter points downwards from -strand 2 into the solvent and
away from the center of the domain, whereas the side chain of
Trp64 is surrounded by side chains from the -helix and
-strand 2 (see Fig. 1). No detectable shift in position of max-
imum emission is noted for the Y64W PpL3316-chain complex;
however, a 5-nm blue shift is seen with the I34W PpL3316-
chain complex suggesting that Trp34 becomes less solvent ex-
posed on complex formation. Details of the spectral character-
istics of the various PpL3316-chain complexes, and the same
proteins in free solution are given in Tables I and II. The data
show that both the I34W and Y64W PpL3316 domains exhibit
fluorescence intensity changes upon complex formation with
-chain. The intensity of Trp34 decreases significantly whether
excited at 280 or 295 nm, whereas that of Trp64 increases
slightly when excited at 295 nm but decreases when excited at
280 nm.
The respective distances of these residues from Tyr53 are
10 Å and 15 Å, respectively, well within the critical distance
FIG. 1. Ribbon diagrams of showing features of mutated
PpL3316 domains. a, the positions of the I34W, Y53F, and L57H
mutations in site 1 and their relative positions to -strand A of bound
-chain. b, the position of Y64W (site 2) and its relationship to -strand
A of bound -chain.
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for efficient Fo¨rster fluorescence resonance energy transfer
(FRET), and Trp64 and Trp34 are almost certainly excited due
to resonance energy transfer from this residue. Previous stud-
ies have shown the fluorescence of Tyr53 is quenched upon
complex formation with -chain (9), and therefore the compo-
nent of Trp64 or Trp34 fluorescence arising due to FRET from
Tyr53 (when excited at 280 nm) will also decrease. The changes
in intensity, and the location of the two Trp groups, 34 and 64,
close to site 1 and in site 2, respectively, support the concept of
-chain binding at both sites.
It should be noted that no fluorescence intensity changes
(excited by light at 295 nm) occur when -chain is mixed with
the I34W/Y53F/L57H or Y64W/A66W PpL3316 proteins (data
not shown) suggesting that binding does not take place at site
1 or site 2 of these mutants, respectively. However, a decrease
in fluorescence intensity at 335 nm or above does occur when
-chain binds to Y64W/A66W PpL3316, and an excitation wave-
length of 280 nm is employed. This is almost certainly due to
decreased FRET from Tyr53 to Trp64 when -chain occupies site
1 (see above).
The largest change in fluorescence intensity occurs when
Y64W/Y53F PpL3316 forms a complex with -chain (ex  280
nm or 295 nm). The Y53F mutation (site 1) has a clear effect on
the fluorescence properties of Y64W in site 2. This could be due
to a direct spectral perturbation (although the expected effect
would be a decrease in fluorescence intensity from Y64W when
excited at 280 nm, see above) or more probably a consequence
of the decrease in affinity at site 1 caused by this mutation (9).
Under the conditions of the above experiments there is only
sufficient -chain to form a 1:1 mol:mol complex with PpL3316.
As a result, sites 1 and 2 are both competing for the available
-chain, with the amount bound to each site being dependent
upon the relative affinities of the sites. Therefore, any mutation
(e.g. Y53F) that causes a decrease in the amount of -chain
bound at site 1 will lead to a concomitant increase in -chain
available to bind to site 2 and thus have an effect on the
magnitude of the signal change from either Trp34 or Trp64.
Pre-equilibrium Binding Studies—Stopped-flow fluorescence
techniques were used to study the binding reactions between
mutant PpL3316 proteins and -chain. They illustrated that the
observed fluorescence changes that occur for the Y64W/Y53F,
Y64W, I34W/Y53F, and I34W mutants seen above are in fact
the net results of more complex changes (Fig. 2).
The single mutation Y64W produces a domain that shows
large and complex changes in fluorescence when mixed with
-chains. When excited at 280 nm a rapid increase in fluores-
cence intensity is followed by a slow and larger decrease. The
binding of I34W to -chain under these conditions also appears
to be a two-step process, both steps being accompanied by a
decrease in fluorescence intensity. Biphasic kinetics such as
these have been observed previously and occur when the mu-
tant F39W PpL3316 is mixed with -chain (9). The unidirec-
tional, biphasic fluorescence intensity changes observed in
those studies are consistent with a system in which the rapid
fluorescence change corresponds to the formation of an encoun-
ter complex that subsequently undergoes a slower local rear-
rangement from a low affinity complex to a high affinity equi-
librium complex. However, this model cannot explain the
reaction progress curves that show more complex bidirectional
fluorescence changes. In view of the recent crystallographic
results that detail the existence of a second, albeit much
weaker, binding site for -chain on PpL3316, we can now recon-
cile these data with a two-site binding model. This model not
only explains the complex fluorescence changes described
above but also allows the Kd for the two binding sites to be
determined.
In this model -chains bind independently to sites 1 (1) and 2
(2) on 1PpL2. The overall Kd for each site will depend upon the
ratios of their dissociation (k1 and k2) and association rate
constants (k1 and k2), respectively. Thus if the two sites have
different Kd values for their respective complexes with -chains
and the rates of association of -chain to the two sites are
similar, then the rates of dissociation from these sites must be
different. Such a phenomenon (17) will explain the biphasic
fluorescence changes described above. For example, consider
TABLE I
Fluorescence spectral characteristics of various PpL3316 domains and
their complexes with 1-chain (ex  280 nm)
PpL construct
Wavelength of emission maximum
Fluorescence
PpL  -chain PpL-chaincomplex
nm %
Y64W 335 335 8.6
Y64W/Y53F 335 335 18.6
I34W 345 340 16.9
I34W/Y53F 345 343 6.8
TABLE II
Fluorescence spectral characteristics of various PpL3316 domains and
their complexes with 1-chain (ex  295 nm)
PpL3316 construct






Y64W 335 335 11.6
Y64W/Y53F 335 335 49.9
I34W 345 340 5.9
I34W/Y53F 345 344 1.7
FIG. 2. Reaction progress curves showing the changes in fluo-
rescence intensity observed upon mixing -chain with various
PpL3316 mutants. 1.5 M -chain was mixed with 1.5 M PpL3316
mutant (Y64W/Y53F/L57H, Y64W/Y53F, Y64W, I34W/Y53F/L57H,
I34W/Y53F, or I34W as indicated) in 20 mM potassium phosphate
buffer, pH 8.0 at 15 °C. The fluorescence values shown are relative to
the initial fluorescence observed for each reaction. Concentrations
quoted are after mixing.
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the situation when PpL3316 is present in excess and the rates of
association to each site are similar. Under these conditions the
-chain will initially bind to both sites 1 and 2. However, if site
2 has a higher dissociation rate than site 1 the occupancy of site
2 decreases and the -chain is redistributed in favor of site 1.
Thus a reporter group in site 2, e.g. Trp64, may show an initial
fluorescence increase, as it becomes less solvent exposed due to
the binding of -chain, followed by a decrease in fluorescence as
the -chain is redistributed in favor of site 1. Similarly, the site
1 reporter group F39W shows a biphasic change on complex
formation. In this case an initial rapid increase in fluorescence
intensity, due to binding of free -chain to this site, followed by
a slower increase, due to the further saturation of available site
1 a consequence of -chain being released from site 2. This is in
accord with previous data (9). An alternative reporter group in
site 1, I34W, which lies on the opposite side of  strand 2 and
points away from the helix, interestingly shows a biphasic
decrease in fluorescence on formation of a complex with
-chain.
If the binding of -chain to each site is independent of the
presence of -chain at the other site, then rates k1, k1, k2, and
k2 will be the same as rates k4, k4, k3, and k3, respectively.
However, in the presence of excess PpL3316 the complex involv-
ing one PpL3316 domain and two -chains (
1PpL2, shown
boxed in Scheme 1) will not be present in significant amounts.
This model is supported by the dramatic effects of the addi-
tional mutation Y53F on the fluorescence properties and the
reaction progress curves observed on complex formation. It
virtually eliminates the second, slow decrease in fluorescence
intensity shown by Trp64 (Fig. 2) and is almost certainly attrib-
utable to the decreased affinity of site 1, a result of the Y53F
replacement (9). Thus if the affinity of site 1 is decreased to, or
below that, of site 2, then under the conditions used, more
-chain will remain bound to site 2, and the fluorescence in-
tensity at equilibrium from Trp64 will be higher. This conclu-
sion is supported by experiments using the mutant I34W/Y53F.
This protein gives a reaction progress curve that appears to
have a single-phase fluorescence change with a decreased am-
plitude compared with that observed for the binding of the
single mutant I34W to -chain. These observations are consist-
ent with the idea that the Y53F mutation reduces the affinity
of site 1 close to that of site 2.
Finally, I34W/Y53F/L57H PpL3316 containing the binding
site mutations Y53F/L57H with the site 1 reporter Trp34 shows
no fluorescence change when mixed with -chain. This is be-
cause binding at site 1 has been substantially reduced/elimi-
nated, and any significant remaining -chain binding is due to
site 2. This is supported by the results gained from experiments
using the same site mutations but with the Y64W reporter
(Y64W/Y53F/L57H PpL3316). This domain binds -chain result-
ing in the largest increase in fluorescence intensity (see Fig. 2).
Assuming that the spectral response of the Trp64 reporter
group, excited by light at 295 nm, is not affected directly by the
substitutions on the opposite side of the domain, these data
suggest that the fluorescence intensity of Y64W PpL3316 at
equilibrium reflects the occupancy of site 2 only. Thus the large
fluorescence change given by Y64W/Y53F/L57H and the ab-
sence of any fluorescence change for the same reaction with
I34W/Y53F/L57H support the proposal that all of the bound
-chain is located at site 2.
If the binding model described in the above scheme is correct
then one would expect to see different reaction progress curves
when the experiment is repeated with increasing concentra-
tions of -chain. Eventually there will be sufficient -chain to
occupy both binding sites to give the species 1PpL2, and
thus the reaction progress curves will become monophasic.
Such an experiment is described in Fig. 3, which displays three
reaction curves in which 1.5 M Y64W PpL3316 is mixed with
1.8, 9.9, and 28.8 M -chain. There is a clear reduction in the
amplitude of the slow decrease in fluorescence as the concen-
tration of -chain is increased. This reflects the increased oc-
cupancy of site 2 at equilibrium due to the higher concentration
of -chain.
Do the Mutations Alter the Structure of the PpL Domain?—
Circular dichroism studies (see Fig. 4) have shown that wt,
L57H, Y53F, and Y53F/L57H domains have identical far UV
CD spectra suggesting that the substitutions have not dis-
turbed the secondary structures of the proteins. The presence
of Trp residues in position 34 or 64 leads to an increase in
ellipticity between 205 and 210 nm that is almost certainly due
to spectral contributions from the aromatic side chains rather
than disruption of the secondary folding of the protein. Fur-
thermore, the structure of Y64W obtained by x-ray studies
shows no significant backbone differences to that of the wt
PpL3316 (18). Further mutations, e.g. Y53F, L57H, or Y53F/
SCHEME 1. Two-site binding model.
FIG. 3. Reaction progress curves showing the changes in fluo-
rescence intensity observed upon reaction between Y64W
PpL3316 and -chain. The reaction was initiated by mixing 1.5 M
Y64W PpL3316 with 1.8 M -chain (a), 9.9 M -chain (b), and 28.8 M
-chain (c) in 20 mM potassium phosphate buffer, pH 8.0 at 15 °C.
Concentrations quoted are after mixing.
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L57H made to the I34W or Y64W domains, caused no further
spectral changes again indicating that they do not disrupt the
folding of PpL3316.
Does the Binding Reaction Involve a Change in Structure of
the Complex?—The determination of the x-ray crystallographic
structures of the complexes between wt PpL3316 and a human
Fab (10) and Y64W PpL3316 and a mouse Fab (18) have shown
that the secondary structure of the free PpL3316 is the same as
that of PpL3316 in the complex. Furthermore, the far-UV CD
spectrum of wt PpL3316 is the same in the absence or presence
of an equimolar concentration of -chain (see inset to Fig. 4)
suggesting that there is no change in secondary structure on
complex formation.
Determination of Kd for Complexes at Sites 1 and 2—By
determining the rates k1, k1, k2, and k2 for -chain binding to
sites 1 and 2 of PpL3316, respectively, the Kd of the complex at
each site can be determined. In experiments using domains
with both sites functioning then the overall observed rate of
association, ka, will be a combination of the association rates
for each site (k1  k2, see Fig. 5). Thus to determine the
association rate to each site individually it was necessary to
eliminate the alternative site in each case. This was achieved
by the mutations Y53F/L57H and A66W on the I34W or Y64W
templates. These remove binding capacity at sites 1 and 2,
respectively. ka can be calculated from the slope of a plot of the
observed rate, kapp, against the concentration of the variable
ligand (PpL3316). Such data using various PpL3316 mutants are
given in Table III. In the absence of -chain binding at site 1
the reaction of -chain with site 2 of the Y64W/Y53F/L57H
PpL3316 mutant is a simple bimolecular binding process and
the observed rate of reaction kapp  k2[Y64W/Y53F/L57H
PpL3316]  k2 (see Fig. 5). The variation of kapp with varying
concentrations of Y64W/Y53F/L57H PpL3316 is shown in the inset
to Fig. 5, and the value of k2 is 0.15  0.02 M
1 s1 (Table III).
Similarly experiments show that k1 for binding at site 1 (using the
mutant I34W/A66W) is 0.25 0.01 M1 s1 at 25 °C. The sum of
these two association rate constants (0.40 M1 s1) is very close to
that determined for domains in which binding occurs to both sites
simultaneously, as described above, e.g. Y64W (0.35  0.03 M1
s1) or I34W (0.33  0.02 M1 s1).
FIG. 4. Far-UV CD spectra of wt, I34W, and Y64W PpL3316. The spectra shown are each the average of three scans using 20 M wt PpL3316
(dashed line), Y64W (solid line), or I43W (dotted line) in 20 mM potassium phosphate buffer, pH 8.0, 15 °C. The inset shows the spectrum of 20 M
-chain (f), 20 M wt PpL3316 (dotted line), the summated spectra of -chain (20 M) and PpL3316 (20 M) (Œ), and the spectrum of a mixture of the
two (solid line).
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To corroborate these calculations we used domains with
the Trp34 reporter and determined k1 and k1 for the reaction
by rapidly mixing a constant amount of the PpL3316 domain
with various excess concentrations of -chain, the latter al-
ways in large excess so that pseudo-first order conditions can
be achieved. The observed rate of reaction kapp will depend
upon the concentration of -chain, and a plot of kapp against
-chain concentration yielded a line of slope k1, in this case
0.23  0.04 M1 s1 (data not shown), which is in close
agreement with the values determined by other methods (see
Table III).
Determination of the Rates of Dissociation of the Complexes—
Although estimates of the dissociation rates k1 or k2 can be
obtained from the intercept on the ordinate of the plot shown in
the inset to Fig. 5, these are prone to large errors when their
values are so low (19). Therefore rates of dissociation of the
complexes between PpL3316 domains and -chain were meas-
ured as described under “Experimental Procedures,” and the
data are summarized in Fig. 6, a–c, and Table III. The disso-
ciation of the -chain from the complex at site 1 of I34W
PpL3316 gives rise to a slow, single-phase fluorescence increase,
with a rate of 0.013  0.001 s1. The rate of dissociation of the
FIG. 5. A reaction progress curve showing the changes in fluorescence intensity observed upon the reaction between -chain and
Y64W/Y53F/L57H PpL3316. Both proteins (1.5 M -chain and 15 M PpL3316 after mixing) were dissolved in 20 mM potassium phosphate buffer,
pH 8.0. Inset, the variation of kapp upon mixing 1.5 M -chain with various concentrations of Y64W/Y53F/L57H PpL3316.
TABLE III
The rates of association, dissociation, and Kd values for the various PpL3316-chain complexes (n  3)
Standard deviations are only given for experimentally determined values. ND is given where no reporter group is present in the respective site
to be determined.
PpL construct ka
Site 1 Site 2
k1 k1 Kd k2 k2 Kd
M
1 s1  104 M1 s1  104 s1  103 M  109 M1 s1  104 s1  103 M  107
Y64W 35  3 20a 8  1 38 15b 560  20 37
Y64W/Y53F 33  6 18a ND ND 15b 410  30 28
Y64W/Y53F/L57H 15  2 No detectable binding 15  2 500  20 34  7
I34W 33  2 18a 13  1 68 15b ND ND
I34W/Y53F 33  3 18a 840  13 4400 15b ND ND
I34W/A66W 25  1 25  1 12  1 48  8 No detectable binding
a Values of k1 calculated by subtraction of k2 (determined for the Y64W/Y53F/L57H--chain interaction) from ka (the combined rates of k1 and k2).
b The value of k2 determined from experiments using Y64W/Y53F/L57H PpL in which binding at site 1 has been eliminated.
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I34W/Y53F PpL3316-chain complex (containing the additional
Y53F mutation) is 65-fold greater (0.84  0.01 s1), thus
giving rise to a large increase in the value of Kd (see Table III)
as noted previously (9).
The fluorescence changes that accompany the dissociation of
the Y64W PpL3316-chain complex can be resolved into two
distinct steps when an excitation wavelength of 280 nm is used.
A fluorescence decrease occurs with a rate of 0.56  0.02 s1,
followed by a much slower fluorescence increase with a rate of
0.008  0.001 s1, the latter of which is comparable with the
rate of dissociation noted for the I34W PpL3316-chain com-
plex. The dissociation of the Y64W/Y53F PpL3316-chain and
Y64W/Y53F/L57H PpL3316-chain complexes are both accom-
panied by single-phase fluorescence decreases with rates of
0.41  0.03 s1 and 0.50  0.02 s1, respectively. Thus by
introducing the mutations Y53F or Y53F/L57H into the Y64W
PpL3316 template the initial phase of dissociation of the
PpL3316-chain complex is relatively unaffected but the slower
dissociation step is no longer observed suggesting this is due to
dissociation from site 1. The Kd values for the complexes
formed by the above PpL3316 domains and -chain are given in
Table III.
When the dissociation experiment with the Y64W
PpL3316-chain complex was repeated using an excitation
wavelength of 295 nm, only the initial fluorescence decrease
was apparent (Fig. 6c). We can conclude from this that the
initial fluorescence decrease is due to changes in the envi-
ronment of Trp64 as the -chain dissociates from site 2. The
slower fluorescence change noted when the excitation wave-
length is 280 nm arises from increased FRET from Tyr53 as
the complex at site 1 dissociates (removing quenching from
Tyr53). Therefore it is possible to simultaneously observe
dissociation at sites 1 and 2. Using the values of the rates of
association (k2) and dissociation (k2) of the Y64W/Y53F/
L57H PpL3316-chain complex from the above experiments
the Kd at site 2 is 3.4  0.70 M (Table III).
Sequential Mixing Stopped-flow Fluorimetry—In the origi-
nal single site binding model shown below (9), it was proposed










In this scheme ka and kdiss represent the rates of association
and dissociation, respectively, of the encounter complex PpL,
and kf and kr represent the forward and reverse rates of the
structural rearrangement, respectively.
In the proposed model (9) the transition from PpL to
[PpL]* was suggested to increase the affinity by 30-fold.
Thus under equilibrium conditions, the majority of the PpL and
-chain would be present in the form of the high affinity com-
plex. Also dissociation of the encounter complex occurs rapidly,
while dissociation of the equilibrium complex is rate limited by
kr (9). Therefore upon dissociation of the complex at equilib-
rium most of the observed fluorescence change would occur
with the rate kr. However, if dissociation of the PpL-chain
complex is invoked shortly after the mixing of PpL and -chain,
before the encounter complex has undergone the structural
rearrangement, the observed rate would be kdiss, that of the
dissociation of the encounter complex. When both encounter
and equilibrium complexes are present, the observed dissocia-
tion profile would be expected to be biphasic, the amplitude of
each phase being dependent on the relative abundance of each
complex.
However, sequential-mixing stopped-flow studies on the
dissociation of the I34W PpL3316-chain complex reveal a
single-phase fluorescence increase upon dissociation. Regard-
less of the incubation time prior to initiation of dissociation,
a rate constant of 0.01 s1 was observed. Therefore, the
formation of the I34W PpL3316-chain complex does not ap-
pear to occur by a two step process involving a structural
rearrangement.
Isothermal Titration Calorimetry—Isothermal titration
calorimetry was used to verify the Kd values obtained for
-chain binding to sites 1 and 2 of PpL3316 determined using
the fluorimetric methods above. To attempt to resolve bind-
ing to sites 1 and 2, -chain was titrated into wt PpL3316. As
a result of the very high concentration of -chain required
when used as the titrant the data required significant cor-
rection for the contribution to the enthalpy profile due to
-chain dilution. The Kd values for sites 1 and 2 were esti-
mated to be 21.1  10.21 nM and 7.5  3.1 M. respectively
(see Table IV). The enthalpic contributions to binding at sites
1 and site 2 were 54.3  0.7 kJ/mol and 28.1  6.2 kJ/mol,
respectively, and the entropic changes were 41.4 and 0.7
J/mol/degree, respectively.
FIG. 6. Fluorescence intensity changes observed upon the dis-
sociation of PpL3316-chain complexes at pH 8.0 and 15 °C. a,
emission at wavelengths greater than 335 nm, using an excitation
wavelength of 280 nm, observed upon the dissociation of the I34W
PpL3316-chain and Y64W PpL3316-chain complexes. b, emission at
wavelengths greater than 335 nm, using an excitation wavelength of
280 nm, upon dissociation of the I34WY53F PpL3316-chain, Y64W/
Y53F, PpL3316-chain, and Y64W/Y53F/L57H PpL3316-chain com-
plexes. c, emission at wavelengths greater than 335 nm, using an
excitation wavelength of 295 nm, upon dissociation of the Y64W
PpL3316-chain complex.
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However, to accurately determine these values for each site,
mutants in which either site 1 or site 2 had been eliminated
were used. Titration of Y64W/Y53F/L57H PpL3316 into -chain
allows the binding at site 2 to be measured. Clear enthalpy
profiles are obtained (see Fig. 7), while titration of Y64W/Y53F/
L57H PpL3316 into buffer shows insignificant enthalpy
changes. Analysis of the heat changes of the titrations fitted a
one site binding model and indicated a Kd value of 4.6 0.8 M,
an enthalpy change of 21.3  1.2 kJ/mol and an entropic
change of 28.4  5.6 J/mol/degree.
A66W PpL3316 was similarly used to study binding to site 1
in the absence of binding at site 2. The A66W titration into
-chain gives an enthalpy profile that fits a one site binding
model with a Kd equal to 37.5  7.3 nM, an enthalpy change of
40.2  0.3 kJ/mol and an entropic change of 2.8  1.1
J/mol/degree.
CONCLUSIONS
The experiments described above show conclusively that a
PpL3316 domain has two binding sites for -chain of different
affinities. The placement of unique Trp residues in either of the
two binding sites has facilitated the binding constants to be
determined and a model developed that explains the complex
fluorescence signal changes noted previously. Estimates of Kd
FIG. 7. Binding isotherms for the re-
actions between wt (a), A66W (b), and
Y53F/L57H PpL3316 and 1-light chain
(c) in 20 mM potassium phosphate
buffer, pH 8.0 at 15 °C. a, aliquots of 360
M -chain were titrated into 15 M wt
PpL3316 corrected for the heat changes as-
sociated with the dilution of the -chain.
b, 737 M A66W PpL3316 was titrated into
28.3 M 1-chain. c, 650 M Y53F/L57H
PpL3316 were titrated into 25 M 1-chain.
Binding data from these titrations were
analyzed using the manufacturer’s
software.
TABLE IV
Isothermal titration calorimetric analysis of 1-chain binding to sites 1 and 2 on PpL3316 N  stoichiometry of binding sites (n  3)
PpL
Site 1 Site 2
N Kd H S N Kd H S
nM kJ/mol J/mol/degree M kJ/mol J/mol/degree
wta 1.0  0.0 21.1  10.2 54.3  0.7 41.4a 1.3  0.2 7.5  3.1 28.2  6.2 0.7a
A66W 1.3  0.1 37.5  7.3 40.2  0.3 2.8  1.1 No detectable binding
Y53F/L57H No detectable binding 1.3  0.0 4.6  0.8 21.3  1.8 28.4  5.6
a Parameters determined from the analysis of one data set. For experimental conditions see “Experimental Procedures.”
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by such techniques as enzyme-linked immunosorbent assay
will reflect the presence of both sites. Thus we have resolved
the issue by the production of mutants that have binding at one
site or the other eliminated under these experimental
conditions.
Fig. 2 shows that the final level of fluorescence (ex  295
nm) from the complex formed by mixing a 1:1 mol:mol ratio of
Y64W PpL3316 and -chain is indicative of the relative occu-
pancy of site 2. Thus if all of the bound -chain is at site 1, then
there is little fluorescence increase at equilibrium from the
Trp64 and vice versa. A domain with two sites of equal affinity
would show equilibrium fluorescence intensity half way be-
tween the two extremes described above. We estimate that for
the Y64W PpL3316-chain complex, greater than 95% of the
-chain is bound to site 1, and this is reflected by an 2% net
increase in the fluorescence intensity at equilibrium. The re-
sidual fluorescence intensity at equilibrium given by Y64W/
Y53F is more than half of the fluorescence intensity difference
given by Y64W and Y64W/Y53F/L57H (which shows no binding
at site 1). This therefore suggests that the Y64W/Y53F has an
affinity for -chain at site 1 that is lower than its affinity at site
2. This is supported by the Kd values for the various complexes
shown in Table III in which the Kd for the I34W/Y53F
PpL3316-chain complex (site 1) is 4.4 M and that for the
Y64W/Y53F/L57H PpL3316-chain (site 2) is 3.4 M. In the
Y64W/Y53F/L57H complex 100% of the bound -chain is at site
2, and hence this has a Kd equal to 3.4  0.7 M (see Table III).
The new model that explains the biphasic fluorescence
changes that occur on complex formation is consistent with
previous data (9), although the previously proposed structural
rearrangement (9), suggested by a slow change in fluorescence
with a first order rate constant that is independent of the
concentration of ligand, is now known to be the dissociation of
-chain from the weaker site. Possible alternative models in-
volving oligomeric forms of the protein can be eliminated as
sedimentation studies carried out on PpL3316 have confirmed
that the domain exists as a monomer in solution.2
The Y53F mutation dramatically increases the rate of disso-
ciation of -chain from site 1 due to the loss of the hydrogen
bond formed between the hydroxyl group and the peptide car-
bonyl group of Thr20. This leads to a decrease in affinity of at
least 90-fold to yield a Kd of 4.42 M, higher than in a previous
report (9). However, it is now clear from the studies described
in this paper that the affinity (3.2 M) measured in (9) was for
-chain binding that was occurring at the then unreported
weaker binding at site 2.
To date, the binding of wt PpL3316 to two different -chains
has been studied. These are a human 1-chain (1T) described
here and the other a human Fab (2A2 (10)). Additionally the
binding of mutated PpL3316 domains to a murine 9 (Fab
19D9D6) has been studied (12). All of these confirm the pres-
ence of two binding sites per domain although the elimination
of site 2 for the murine 9 (Fab 19D9D6) has been demon-
strated for the mutant D55A (12). Binding at the second site is
not easily detected due to the presence of the much higher
affinity site 1. However, this problem is eliminated when site 1
is either weakened or abrogated and thus by use of suitable
mutants we have in these studies been able to measure the
affinity of site 2 for -light chains.
Because the binding interactions at sites 1 and 2 involve
backbone and different side chain contacts between PpL3316
and -chain, it is probable that the relative affinities of each
site for -chains may depend upon the subclass or origin of the
-chain. This may well offer an advantage to the bacterium,
allowing it to maximize potential binding capacity.
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